Ledger.Open graph →
SEC Form D · filed December 9, 2010

Selexagen Therapeutics, Inc

Offering
$497K
Sold
$497K
Exemption
—
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

People & firms on this filing (8)

Robert J. Frohwein · Atlanta, GAExec · DirectorMark A. Ross · Redwood City, CADirectorMarc J. Gorlin · Atlanta, GAExec · DirectorKathryn T. Petralia · Atlanta, GADirectorLauren G. Otsuki · San Diego, CAExec · DirectorPatrick O'Connor · San Diego, CAExec · DirectorRandall Woods · San Diego, CADirectorScott L. Glenn · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗